Protea Fund - Sectoral Biotech Opportunities Fund Class IF Fonds
8,21
EUR
-0,20
EUR
-2,38
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 9,18% |
| Amgen Inc | US0311621009 | 8,28% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 7,56% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,83% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,65% |
| AstraZeneca PLC ADR | US0463531089 | 4,58% |
| argenx SE ADR | US04016X1019 | 3,58% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,84% |
| Insmed Inc | US4576693075 | 2,69% |
| BeiGene Ltd ADR | US07725L1026 | 2,64% |
| Sonstige | 48,16% |